✨ Free AI Report
Evonetix: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Evonetix
Company Research

Evonetix: Business Overview, Financials & Competitive Analysis

Evonetix is a Cambridge, United Kingdom-based biotechnology company that develops DNA synthesis technology utilizing a specialized electronic silicon chip approach to produce high-fidelity genetic material. The compan...

Analyst-debate audio for Evonetix

AskCyborg analysts argue the bull and bear cases for Evonetix across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
7/ 10Solid

Cyborg Score thesis

Capital-efficient synthetic biology innovator addressing DNA synthesis bottleneck with proprietary chip-based platform,...

Read the full analyst-debate transcript →
Industry Biotechnology
5 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 9, 2026
AI-Generated Research
30+ Page Report

Get the Latest Evonetix Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Evonetix Overview

Pro stress-test →

Evonetix is a Cambridge, United Kingdom-based biotechnology company that develops DNA synthesis technology utilizing a specialized electronic silicon chip approach to produce high-fidelity genetic material. The company is developing technology that will put a gene foundry into every lab, giving researchers access to high-quality, gene-length DNA at unprecedented speed and scale.

Strategic Profile

Pro stress-test →

The platform uses silicon arrays for DNA synthesis of genes having high GC content, enabled by semiconductor microfabrication which enables various miniaturized reaction sites. CEO Colin McCracken notes the ultimate goal is to provide a desktop synthesiser to all labs for researchers to utilize, with recent installation at Imperial College London representing a significant step forward in delivering on this vision.

Competitive Landscape

Pro stress-test →

Key competitors include DNA Script, Quantapore, Bionano Genomics, Pacific BioSciences of California, and Oxford Nanopore Technologies. DNA Script develops enzymatic DNA synthesis, producing the SYNTAX platform benchtop DNA printer for custom DNA oligos, founded in 2014 and based in France. Molecular Assemblies focuses on enzymatic DNA synthesis serving therapeutics, vaccines, immunotherapy, agriculture, and nanotechnology sectors, founded in 2013 in San Diego.

Industry Context

Evonetix operates in Biotechnology.

Key facts

Founded: 2015 · Headquarters: Cambridge, United Kingdom · Employees: 25 employees · Revenue: $6.4 million (2026) · Market cap: N/A

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Evonetix.

  • Proprietary silicon array technology uses semiconductor microfabrication to enable miniaturized reaction sites for DNA synthesis
  • Platform comprises patented semiconductor chip designs and proprietary, thermally controlled synthesis chemistry for novel chemistry approaches and process control
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • June 2026Installed first DNA synthesis development platform at Imperial College London
  • February 2023Completed $24 million Series B financing, extending total Series B funding to over $54 million
  • +1 moreTrack every material event for Evonetix as it happens. Explore monitoring →
Get alerted when Evonetix has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

DNA Script SYNTAXEnzymatic benchtop DNA printer for custom DNA oligos and research applications→Molecular Assemblies DNAEnzymatic DNA synthesis for therapeutics, vaccines, agriculture, and nanotechnology→Oxford Nanopore TechnologiesNanopore-based DNA sequencing and long-read genomics→Pacific BiosciencesLong-read sequencing systems and genomics platforms→QuantaporeDNA sequencing and analysis technology→

Compare Evonetix with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Evonetix operates in Biotechnology. See how the rest of the sector scores on the Cyborg framework.

Top companies in Biotechnology by Cyborg Score

Browse Biotechnology research →
NEW · MCP server

Ask your AI assistant about Evonetix

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Evonetix and its top competitor on Cyborg Score”
“What did Evonetix do this quarter?”
“Is Evonetix a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Evonetix do?+
Evonetix is a Cambridge, United Kingdom-based biotechnology company that develops DNA synthesis technology utilizing a specialized electronic silicon chip approach to produce high-fidelity genetic material. The compan...
What is Evonetix's Cyborg Score?+
Evonetix has a Cyborg Score of 7/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Evonetix's main competitors?+
Named competitors include DNA Script SYNTAX, Molecular Assemblies DNA, Oxford Nanopore Technologies, Pacific Biosciences. The full competitive landscape is in the AskCyborg report.
How can I get the full Evonetix research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Evonetix research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Evonetix over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Biotechnology research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8Abivax SA8Bavarian Nordic A/S8Beam Therapeutics Inc.8CG Oncology, Inc.8Cogent Biosciences, Inc.8COMPASS Pathways plc8CSL Limited8Eckert & Ziegler SE8Krystal Biotech, Inc.8Legend BiotechTop companies in Biotechnology by Cyborg Score